# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
On September 8, 2025, a purported stockholder filed a derivative action (the "Derivative Action") on behalf of Nutex He...
Maxim Group analyst Anthony Vendetti maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $225 t...
On August 22, 2025, a putative securities class action complaint was filed in the United States District Court for the Southern...
Financial highlights for the three months ended June 30, 2025:Total revenue was $244.0 million for the three months ended June ...
HOUSTON, Aug. 14, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a phy...